New York-based pharmacy delivery startup Capsule has raised $20m in funding from Thrive Capital. Capsule aims to streamline the supply chain and cut out third parties to reduce costs and offer customers better delivery options. It will also face competition in the tech space. The company is currently working with a number of major pharmaceutical companies including Pfizer, Novartis, Johnson & Johnson, Merck, AstraZeneca, GlaxoSmithKline, Sanofi Pasteur, Takeda Pharmaceutical Co., Sound Ventures and Virgin Group also participated in the funding round.
New York-based pharmacy delivery startup Capsule has raised $20m in funding from Thrive Capital. Capsule aims to streamline the supply chain and cut out third parties to reduce costs and offer customers better delivery options. The company is currently working with a number of major pharmaceutical companies including Pfizer, Novartis, Johnson & Johnson, Merck, AstraZeneca, GlaxoSmithKline, Sanofi Pasteur, Takeda Pharmaceutical Co., Sound Ventures and Virgin Group also participated in the funding round.